156 related articles for article (PubMed ID: 14557482)
1. The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta.
Luo X; Xu J; Chegini N
J Clin Endocrinol Metab; 2003 Oct; 88(10):4967-76. PubMed ID: 14557482
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
Luo X; Xu J; Chegini N
Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
[TBL] [Abstract][Full Text] [Related]
3. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
[TBL] [Abstract][Full Text] [Related]
4. Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells.
Kim MR; Park DW; Lee JH; Choi DS; Hwang KJ; Ryu HS; Min CK
Mol Hum Reprod; 2005 Nov; 11(11):801-8. PubMed ID: 16403803
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells.
Luo X; Ding L; Chegini N
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E991-E1001. PubMed ID: 15265761
[TBL] [Abstract][Full Text] [Related]
6. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.
Mori Y; Chen SJ; Varga J
Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
8. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Luo X; Ding L; Ripley D
Mol Cell Endocrinol; 2003 Nov; 209(1-2):9-16. PubMed ID: 14604812
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the transforming growth factor-beta/Smad signaling pathway in the epithelium of oral lichen.
Karatsaidis A; Schreurs O; Axéll T; Helgeland K; Schenck K
J Invest Dermatol; 2003 Dec; 121(6):1283-90. PubMed ID: 14675171
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
[TBL] [Abstract][Full Text] [Related]
13. Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells.
Liu L; Santora R; Rao JN; Guo X; Zou T; Zhang HM; Turner DJ; Wang JY
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1056-67. PubMed ID: 12855402
[TBL] [Abstract][Full Text] [Related]
14. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells.
Yanagisawa K; Osada H; Masuda A; Kondo M; Saito T; Yatabe Y; Takagi K; Takahashi T; Takahashi T
Oncogene; 1998 Oct; 17(13):1743-7. PubMed ID: 9796704
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture.
Zhao J; Lee M; Smith S; Warburton D
Dev Biol; 1998 Feb; 194(2):182-95. PubMed ID: 9501027
[TBL] [Abstract][Full Text] [Related]
18. Deficient Smad7 expression: a putative molecular defect in scleroderma.
Dong C; Zhu S; Wang T; Yoon W; Li Z; Alvarez RJ; ten Dijke P; White B; Wigley FM; Goldschmidt-Clermont PJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3908-13. PubMed ID: 11904440
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
